Clinical Trial to Compare the Pharmacokinetics Profile of YJAT Sustained Release Tablet and ULTRACET Immediate Release Tablet After Oral Administration to Healthy Male Subjects

Trial Profile

Clinical Trial to Compare the Pharmacokinetics Profile of YJAT Sustained Release Tablet and ULTRACET Immediate Release Tablet After Oral Administration to Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jan 2015

At a glance

  • Drugs Tramadol/paracetamol (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Yungjin Pharm Co
  • Most Recent Events

    • 24 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top